Literature DB >> 16814323

Are dementia and depression in Parkinson's disease related?

Abraham Lieberman1.   

Abstract

INTRODUCTION: Depression and dementia are common problems in PD. As the depression and dementia of PD share many symptoms such as apathy, anhedonia, anergia, and agitation, it is reasonable to ask if they are related.
METHODS: 106 consecutive PD patients, unselected for depression or dementia were evaluated for depression using the Hamilton Depression Scale (Ham-D21). They were also evaluated using a modified neuropsychiatric inventory (NPI). Following the above, 100 consecutive PD patients were evaluated for dementia using Folstein's Mini Mental Status Examination (MMSE). They were also evaluated using the modified NPI.
RESULTS: 29 of the first series of patients, 27%, were depressed, score of > or =14 on the Ham-D21. 8 of the second series of consecutive patients, 18%, were demented, score < or =24 on the MMSE. Depressed and demented patients were significantly more likely to suffer from apathy, anhedonia, mood lability, daytime drowsiness, paranoia, and hallucinations. Demented patients were significantly older, had PD longer, were more disabled and more likely to be depressed. COMMENT: The commonality of certain symptoms in demented and depressed patients suggests that dementia and depression in PD may be related and that, in PD depression may be a fore-runner of dementia. Five year follow-up of these patients supports this suggestion.

Entities:  

Mesh:

Year:  2006        PMID: 16814323     DOI: 10.1016/j.jns.2006.05.022

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  15 in total

1.  Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson's disease.

Authors:  Juan Carlos Gómez-Esteban; Beatriz Tijero; Johanne Somme; Roberto Ciordia; Koldo Berganzo; Idoia Rouco; Jose Luis Bustos; Maria Antonia Valle; Elena Lezcano; Juan J Zarranz
Journal:  J Neurol       Date:  2010-10-19       Impact factor: 4.849

2.  Clinical correlates of depressive symptoms in familial Parkinson's disease.

Authors:  Nathan Pankratz; Karen S Marder; Cheryl A Halter; Alice Rudolph; Cliff W Shults; William C Nichols; Tatiana Foroud
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

Review 3.  The cholinergic system and Parkinson disease.

Authors:  Nicolaas I Bohnen; Roger L Albin
Journal:  Behav Brain Res       Date:  2010-01-07       Impact factor: 3.332

Review 4.  Depression and apathy in Parkinson's disease.

Authors:  Irene Hegeman Richard
Journal:  Curr Neurol Neurosci Rep       Date:  2007-07       Impact factor: 5.081

5.  Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia.

Authors:  N I Bohnen; D I Kaufer; R Hendrickson; G M Constantine; C A Mathis; R Y Moore
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-06       Impact factor: 10.154

Review 6.  Cholinergic dysfunction in Parkinson's disease.

Authors:  Martijn L T M Müller; Nicolaas I Bohnen
Journal:  Curr Neurol Neurosci Rep       Date:  2013-09       Impact factor: 5.081

7.  Depression in patients with Parkinson's disease and the associated features.

Authors:  Jin Zheng; Shenggang Sun; Xian Qiao; Yudong Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-12-29

8.  Are verbal fluency and nonliteral language comprehension deficits related to depressive symptoms in Parkinson's disease?

Authors:  Christina Tremblay; Oury Monchi; Carol Hudon; Joël Macoir; Laura Monetta
Journal:  Parkinsons Dis       Date:  2012-02-12

9.  Predictors of cognitive impairment in an early stage Parkinson's disease cohort.

Authors:  Michele T M Hu; Konrad Szewczyk-Królikowski; Paul Tomlinson; Kannan Nithi; Michal Rolinski; Clara Murray; Kevin Talbot; Klaus P Ebmeier; Clare E Mackay; Yoav Ben-Shlomo
Journal:  Mov Disord       Date:  2014-01-06       Impact factor: 10.338

Review 10.  Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease.

Authors:  Santiago Perez-Lloret; Francisco J Barrantes
Journal:  NPJ Parkinsons Dis       Date:  2016-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.